MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Translating Real-World Parkinsonian Facial Kinematics onto Diverse Digital Avatars

    C. Gundler, A. Wiederhold, M. Pötter-Nerger (Hamburg, Germany)

    Objective: To support the development of a smart textile with facial sensors and present a novel continuous monitoring approach, we derived and rendered digital twins…
  • 2026 International Congress

    Levodopa–Entacapone–Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: a Four-Year Real-Life Experience

    J. Szasz, V. Constantin, K. Orban Kis, R. Szasz, S. Bataga, R. Neagoe, M. Ciorba, K. Kelemen, I. Mihaly, K. Biro, S. Szatmari (TARGU MURES, Romania)

    Objective: To describe the improvement of motor complications in patients with advanced Parkinson’s Disease (APD) treated with Levodopa-Entacapone-Carbidopa Intestinal Gel (LECIG). Background: The continuous enteral…
  • 2026 International Congress

    Fracture Burden and Health-Related Quality of Life in Older Adults with Parkinson’s Disease in Rural India: A Community-Based Study

    B. Kuanar, D. Panda (Bhubaneswar, India)

    Objective: This study aimed to examine the relationship between fracture history and health-related quality of life (HRQoL) among elderly individuals with Parkinson’s disease residing in…
  • 2026 International Congress

    Microstructural cortical alterations are related to cognitive and disease severity in progressive supranuclear palsy

    C. Garcia Vicente, J. Pardo, C. Martín-Barceló, I. Roura, C. Falcon, R. Sala-Llonch, A. Campabadal, N. Bargalló, O. Brengaret, C. Brenlla, C. Painous, A. Cámara, M. Martí, Y. Compta, C. Junqué, B. Segura (Barcelona, Spain)

    Objective: To study cortical microstructural alterations in patients with progressive supranuclear palsy (PwPSP) and their associations with both cognitive and clinical symptoms. Background: Midbrain’s atrophy on structural…
  • 2026 International Congress

    Higher Dopaminergic Sensitivity Underlies Dyskinesia Occurrence in Indigenous Sabahan PRKN Parkinson’s Disease

    JCE. Ooi, YK. Chia, YW. Tay, TZ. Toh, A. Ahmad-Annuar, S-Y. Lim, AH. Tan (Kota Kinabalu, Malaysia)

    Objective: To compare dyskinesia occurrence and associated factors in PRKN versus non-PRKN early-onset Parkinson's Disease (EOPD). Background: Biallelic pathogenic PRKN variants represent the commonest recessive…
  • 2026 International Congress

    Boxing-Based Exercise Programs for Parkinson’s Disease: A Review of Motor and Quality-of-Life Outcomes

    C. Hu, T. Tran (San Antonio, USA)

    Objective: To evaluate the effects of boxing-based exercise interventions as an adjunct therapy for individuals with Parkinson’s disease (PD). Background: Parkinson’s disease is the second…
  • 2026 International Congress

    Motion-Capture features associated with Outcome after MRgFUS Vim thalamotomy for Essential Tremor

    Y. Osakada, H. Hirabayashi, A. Kinoshita, H. Ohnishi, H. Ohnishi, R. Morihara, H. Ishiura (Okayama, Japan)

    Objective: To identify factors associated with outcomes after magnetic resonance-guided focused ultrasound (MRgFUS) ventral intermediate nucleus (Vim) thalamotomy using motion-capture analysis of tremor videos in…
  • 2026 International Congress

    Responsiveness of Sensor-Derived Measures From a Smartphone-Based Active Typing Test in the Phase 2b LUMA Study of Parkinson’s Disease

    R. Llorens Arenas, E. Bartholome, S. Belachew, C. Bernasconi, G. Cosne, J. Guo, B. Hersh, D. Jennings, A. Juraver, C. Kanzler, A. Karatsidis, M. Pang, ó. Reyes, A. Rodríguez-Romero, M. Wald, P. Wang, M. Yang, C. Mazzà (Cambridge, USA)

    Objective: Investigate the measurement properties of exploratory sensor-derived measures (SDMs) from a smartphone-based typing test in the LUMA study of BIIB122/DNL151 for Parkinson’s disease (PD).…
  • 2026 International Congress

    Comparison Of Levodopa Dose Frequency And Parkinson’s Kinetigraph Metrics For Screening Advanced Parkinson’s Disease

    N. Ullah, H. Renduchintala, B. Mohamed, J. Adenwalla (Cardiff, United Kingdom)

    Objective: 1. Evaluate how well levodopa dose frequency and Parkinson's Kinetigraph (PKG) metrics correspond with the 5-2-1 criteria for identifying Advanced Parkinson Disease (APD)2. Determine…
  • 2026 International Congress

    An observational study of segmental and generalized isolated dystonia to inform development of new drug therapies

    M. Oldham, N. Lubarr, N. Carlson, T. Snyder, A. Wagle Shukla, H. Jinnah (Cambridge, USA)

    Objective: The goal of this study is to characterize severity and variability of symptoms in people with segmental, multifocal, or generalized isolated dystonia. Standardized data…
  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley